Stephen David Prior

Companies

• AN2 Therapeutics, Inc.Chief Strategy Officer Nov 5, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAN2 Therapeutics, Inc. ANTX59,086 shares²$193.2K at $3.27Jan 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 6, 2026Sold 2,858 shares at $1.01 of AN2 Therapeutics, Inc.²
• Jan 5, 2026Sold 3,604 shares at $1.00 of AN2 Therapeutics, Inc.²
• Nov 4, 2025Sold 765 shares at $1.14 of AN2 Therapeutics, Inc.³
• Feb 26, 2025Granted 28,000 shares of AN2 Therapeutics, Inc.⁴
• Jan 3, 2025Sold 2,029 shares at $1.34 of AN2 Therapeutics, Inc.⁵
• Nov 4, 2024Granted 10,125 shares of AN2 Therapeutics, Inc.⁶